Clinical Trial Update: Cannabis Extract in Refractory Epilepsy Study [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating a cannabis extract for drug-resistant epilepsy was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Drug-resistant Epilepsy

Drugs mentioned

• cannabis extract (cannabis extract)

Snippet

Sponsor: The Epilepsy Research Program of the Ontario Brain Institute | Conditions: Drug Resistant Epilepsy | Phase 3 | Status: TERMINATED